$CTIX Recent News

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$CTIX Recent News







Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price Before Kevetrin Or Prurisol

3:06 a.m. Sept. 14, 2014
- Seeking Alpha





The Antibiotic Resistance Triple Threat

2:05 p.m. Sept. 4, 2014
- Seeking Alpha





Cellceutix completes enrollment in Brilacidin trial

9:45 a.m. Aug. 19, 2014
- Seeking Alpha





Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?

11:38 a.m. Aug. 14, 2014
- Seeking Alpha




10-Q: CELLCEUTIX CORP
10:15 a.m. May 12, 2014
- Edgar Online - (EDG = 10Q, 10K)





Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix

10:34 a.m. April 25, 2014
- Seeking Alpha




10-Q: CELLCEUTIX CORP
5:09 p.m. Feb. 10, 2014
- Edgar Online - (EDG = 10Q, 10K)





Cellceutix Is Significantly Undervalued Considering The Value Of Brilacidin

10:31 a.m. Jan. 28, 2014
- Seeking Alpha





Cellceutix Corp.: A Biotech With High Risk But High Reward

4:17 p.m. Jan. 2, 2014
- Wall St. Cheat Sheet





Cellceutix: An Undiscovered Company Set To Rise In 2014

10:06 a.m. Dec. 16, 2013
- Seeking Alpha





3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference

6:38 a.m. Nov. 19, 2013
- Seeking Alpha




10-Q: CELLCEUTIX CORP
6:06 p.m. Nov. 8, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-K: CELLCEUTIX CORP
4:01 p.m. Sept. 30, 2013
- Edgar Online - (EDG = 10Q, 10K)




10-Q: CELLCEUTIX CORP
2:18 p.m. May 20, 2013
- Edgar Online - (EDG = 10Q, 10K)





Interview with CEO of Cellceutix Corporation: Leo Ehrlich

9:57 a.m. Nov. 15, 2011
- GuruFocus.com









Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b
Trial; Company Submits Investigational New Drug Application to FDA
for Phase 2 Trial of Brilacidin-OM for Oral Mucositis
3:01 p.m. Sept. 9, 2014
- Marketwire




Cellceutix to Present at Rodman & Renshaw's 16th Annual Global
Investment Conference
11:17 a.m. Sept. 5, 2014
- Marketwire




Cellceutix Appoints Dr. Barry Schechter to Board of Directors as
Company Focuses on Meeting Requirements for Stock Exchange Uplisting
7:01 a.m. Sept. 2, 2014
- Marketwire




Cellceutix Completes Enrollment in Phase 2b Clinical Trial of
Brilacidin for Acute Bacterial Skin and Skin Structure Infections
(ABSSSI)
8:31 a.m. Aug. 19, 2014
- Marketwire




Cellceutix Prepares for Phase 2 Clinical Trial of Brilacidin-OM for
Oral Mucositis
7:01 a.m. Aug. 11, 2014
- Marketwire




Cellceutix Anti-Psoriasis Drug Prurisol Meets Primary Endpoint of
Clinical Trial
6:04 a.m. Aug. 8, 2014
- Marketwire




Cellceutix Believes Brilacidin on Track to Help U.S. Avoid Falling
Into Post-Antibiotic Era; Completion of Enrollment in Phase 2b Trial
for Acute Bacterial Skin and Skin Structure Infections Expected This
Month
7:01 a.m. Aug. 4, 2014
- Marketwire




Cellceutix Announces Breakthrough in the Formulation of Its Novel
Antibiotic Brilacidin(TM), Plans Studies to Treat Diabetic Foot
Ulcers
7:01 a.m. July 14, 2014
- Marketwire




Cellceutix Brilacidin ABSSSI Trial Gets Positive Review by Data
Safety Monitoring Board; Best Possible Outcome, No Treatment-Related
Serious Adverse Events (SAEs)
7:00 a.m. July 7, 2014
- Marketwire




Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant
7:01 a.m. June 23, 2014
- Marketwire




Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering
Eighth Cohort
7:01 a.m. June 16, 2014
- Marketwire




Cellceutix Completes Patient Enrollment in Clinical Trial of Prurisol
7:02 a.m. June 2, 2014
- Marketwire




Cellceutix Signs Material Transfer Agreements for Defensin Mimetic
Compounds With Leading Universities
7:02 a.m. May 27, 2014
- Marketwire




Cellceutix Plans for Entry in Diabetic Foot Wound and Ulcer Market
7:01 a.m. May 19, 2014
- Marketwire




Cellceutix Confident in Its Formidable Antibiotic Arsenal
7:01 a.m. May 12, 2014
- Marketwire




Cohort Completed in Cellceutix Clinical Trial of Prurisol for
Psoriasis
5:56 a.m. May 7, 2014
- Marketwire




Top Five Daily Small Cap Trading List: InVivo Therapeutics Holding Corp, Vapor Group, Inc., Cellceutix Corp, Agenus, Magellan Petroleum Corp
10:02 a.m. April 29, 2014
- PR Newswire - PRF




Cellceutix Corp. Reports Favorable Results on Trial of New Antibiotic
9:08 a.m. April 28, 2014
- ACCESSWIRE




Study Shows Cellceutix Antibiotic Active Against Drug-Resistant
Superbug Klebsiella Pneumoniae
6:31 a.m. April 14, 2014
- Marketwire




Cellceutix Comments on Positive FDA Advisory Vote for Dalbavancin and
Tedizolid
8:04 a.m. April 1, 2014
- Marketwire




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Exro Technologies Reveals Quarterly Progress and Financial Insights

Updated Category News Views 362

Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...

Continue Reading
dsm-firmenich Appoints New Leaders to Propel Future Growth

Updated Category News Views 548

dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...

Continue Reading
Insight Partners Rolls Out $12.5B for Software Innovation Growth

Updated Category News Views 805

Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 123

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Microbiological Testing of Water Market Growth Forecasts

Updated Category News Views 101

The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...

Continue Reading